Contact Us
EN | 简 | 繁 |
Cervical Cancers & Genital Warts
iconArrow
Candidates
Type of Vaccine
Adjuvant Systems
Product Rights
Commercial Rights
R&D Status
Pre-clinical
IND
Phase I
Phase II
Phase III
Commer...
Future Milestone
Candidates:
REC603
More+
Type of Vaccine:

Recombinant HPV 9-valent vaccine

Adjuvant Systems:
Alum
Product Rights:
Self-developed
Commercial Rights:
Global
R&D Status
Pre-clinical
IND
Phase I
Phase II
Phase III
Commercialization
Future Milestone:
Candidates:
REC604b
More+
Type of Vaccine:

Novel adjuvanted recombinant recombinant HPV 9-valent vaccine

Adjuvant Systems:
Undisclosed novel adjuvant
Product Rights:
Self-developed
Commercial Rights:
Global
R&D Status
Pre-clinical
IND
Phase I
Phase II
Phase III
Commercialization
Future Milestone:
Candidates:
REC601
More+
Type of Vaccine:

Recombinant HPV bivalent vaccine(Types 16/18)

Adjuvant Systems:
Alum
Product Rights:
Self-developed
Commercial Rights:
Global
R&D Status
Pre-clinical
IND
Phase I
Phase II
Phase III
Commercialization
Future Milestone:
Candidates:
REC602
More+
Type of Vaccine:

Recombinant HPV bivalent vaccine(Types 6/11)

Adjuvant Systems:
Alum
Product Rights:
Self-developed
Commercial Rights:
Global
R&D Status
Pre-clinical
IND
Phase I
Phase II
Phase III
Commercialization
Future Milestone:
Candidates:
REC604a
More+
Type of Vaccine:

Novel adjuvanted recombinant HPV quadrivalent vaccine

Adjuvant Systems:
BFA04
Product Rights:
Self-developed
Commercial Rights:
Global
R&D Status
Pre-clinical
IND
Phase I
Phase II
Phase III
Commercialization
Future Milestone:
Shingles
iconArrow
Candidates
Type of Vaccine
Adjuvant Systems
Product Rights
Commercial Rights
R&D Status
Pre-clinical
IND
Phase I
Phase II
Phase III
Commer...
Future Milestone
Candidates:
REC610
More+
Type of Vaccine:

Novel adjuvanted recombinant shingles vaccine

Adjuvant Systems:
BFA01
Product Rights:
Self-developed
Commercial Rights:
Global
R&D Status
Pre-clinical
IND
Phase I
Phase II
Phase III
Commercialization
Future Milestone:
Respiratory Diseases Caused by Respiratory Syncytial Virus (RSV)/ Metapneumovirus Infection
iconArrow
Candidates
Type of Vaccine
Adjuvant Systems
Product Rights
Commercial Rights
R&D Status
Pre-clinical
IND
Phase I
Phase II
Phase III
Commer...
Future Milestone
Candidates:
REC625
More+
Type of Vaccine:

Novel adjuvanted recombinant respiratory syncytial virus vaccine

Adjuvant Systems:
BFA01
Product Rights:
Self-developed
Commercial Rights:
Global
R&D Status
Pre-clinical
IND
Phase I
Phase II
Phase III
Commercialization
Future Milestone:
Candidates:
REC627
More+
Type of Vaccine:

Recombinant metapneumovirus vaccine

Adjuvant Systems:
Undisclosed novel adjuvan
Product Rights:
Self-developed
Commercial Rights:
Global
R&D Status
Pre-clinical
IND
Phase I
Phase II
Phase III
Commercialization
Future Milestone:
Human Cytomegalovirus Disease
iconArrow
Candidates
Type of Vaccine
Adjuvant Systems
Product Rights
Commercial Rights
R&D Status
Pre-clinical
IND
Phase I
Phase II
Phase III
Commer...
Future Milestone
Candidates:
REC609
More+
Type of Vaccine:

Recombinant human cytomegalovirus vaccine

Adjuvant Systems:
BFA01
Product Rights:
Self-developed
Commercial Rights:
Global
R&D Status
Pre-clinical
IND
Phase I
Phase II
Phase III
Commercialization
Future Milestone:
Covid-19
iconArrow
Candidates
Type of Vaccine
Adjuvant Systems
Product Rights
Commercial Rights
R&D Status
Pre-clinical
IND
Phase I
Phase II
Phase III
Commer...
Future Milestone
Candidates:
ReCOV
More+
Type of Vaccine:

Recombinant Bicomponent COVID-19 vaccine

Adjuvant Systems:
BFA03
Product Rights:
Co-developed
Commercial Rights:
Global
R&D Status
Pre-clinical
IND
Phase I
Phase II
Phase III
Commercialization
Future Milestone:
Diseases Caused by Hepatitis B Virus Infection
iconArrow
Candidates
Type of Vaccine
Adjuvant Systems
Product Rights
Commercial Rights
R&D Status
Pre-clinical
IND
Phase I
Phase II
Phase III
Commer...
Future Milestone
Candidates:
REC629
More+
Type of Vaccine:

Recombinant Hepatitis B virus vaccine

Adjuvant Systems:
Undisclosed novel adjuvant
Product Rights:
Self-developed
Commercial Rights:
Global
R&D Status
Pre-clinical
IND
Phase I
Phase II
Phase III
Commercialization
Future Milestone:
Candidates:
REC630
More+
Type of Vaccine:

Therapeutic Recombinant Hepatitis B virus vaccine

Adjuvant Systems:
Undisclosed novel adjuvan
Product Rights:
Self-developed
Commercial Rights:
Global
R&D Status
Pre-clinical
IND
Phase I
Phase II
Phase III
Commercialization
Future Milestone:
Herpes Caused by Herpes Simplex Infection
iconArrow
Candidates
Type of Vaccine
Adjuvant Systems
Product Rights
Commercial Rights
R&D Status
Pre-clinical
IND
Phase I
Phase II
Phase III
Commer...
Future Milestone
Candidates:
REC608
More+
Type of Vaccine:

Recombinant herpes simplex virus vaccine

Adjuvant Systems:
BFA01
Product Rights:
Self-developed
Commercial Rights:
Global
R&D Status
Pre-clinical
IND
Phase I
Phase II
Phase III
Commercialization
Future Milestone: